JCXH-212

N/A

Report date: 2026/05/13 09:17:19

Base Information

Drug NameJCXH-212
Drug Alias Nameself-amplifying mRNA cancer vaccine (Jiachen Xihai)sa mRNA cancer vaccine (Jiachen Xihai)JCXH-212
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursNeoplasmsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesImmorna (Hangzhou) Biotechnology Co., Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSeqirusBeijing Cancer Hospital
Inactive CompaniesImmorna (Hangzhou) Biotechnology Co., Ltd
Active IndicationsSolid tumoursInfluenza, Human
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A